NOTCH3 regulates stem-to–mural cell differentiation in infantile hemangioma
Andrew K. Edwards, Kyle Glithero, Peter Grzesik, Alison A. Kitajewski, Naikhoba C.O. Munabi, Krista Hardy, Qian Kun Tan, Michael Schonning, Thaned Kangsamaksin, Jan K. Kitajewski, Carrie J. Shawber, June K. Wu
Andrew K. Edwards, Kyle Glithero, Peter Grzesik, Alison A. Kitajewski, Naikhoba C.O. Munabi, Krista Hardy, Qian Kun Tan, Michael Schonning, Thaned Kangsamaksin, Jan K. Kitajewski, Carrie J. Shawber, June K. Wu
View: Text | PDF
Research Article Vascular biology

NOTCH3 regulates stem-to–mural cell differentiation in infantile hemangioma

Abstract

Infantile hemangioma (IH) is a vascular tumor that begins with rapid vascular proliferation shortly after birth, followed by vascular involution in early childhood. We have found that NOTCH3, a critical regulator of mural cell differentiation and maturation, is expressed in hemangioma stem cells (HemSCs), suggesting that NOTCH3 may function in HemSC-to–mural cell differentiation and pathological vessel stabilization. Here, we demonstrate that NOTCH3 is expressed in NG2+PDGFRβ+ perivascular HemSCs and CD31+GLUT1+ hemangioma endothelial cells (HemECs) in proliferating IHs and becomes mostly restricted to the αSMA+NG2loPDGFRβlo mural cells in involuting IHs. NOTCH3 knockdown in HemSCs inhibited in vitro mural cell differentiation and perturbed αSMA expression. In a mouse model of IH, NOTCH3 knockdown or systemic expression of the NOTCH3 inhibitor, NOTCH3 Decoy, significantly decreased IH blood flow, vessel caliber, and αSMA+ perivascular cell coverage. Thus, NOTCH3 is necessary for HemSC-to–mural cell differentiation, and adequate perivascular cell coverage of IH vessels is required for IH vessel stability.

Authors

Andrew K. Edwards, Kyle Glithero, Peter Grzesik, Alison A. Kitajewski, Naikhoba C.O. Munabi, Krista Hardy, Qian Kun Tan, Michael Schonning, Thaned Kangsamaksin, Jan K. Kitajewski, Carrie J. Shawber, June K. Wu

×

Figure 6

A NOTCH3 inhibitor, NOTCH3 Decoy, blocks IH development and mural cell differentiation.

Options: View larger image (or click on image) Download as PowerPoint
A NOTCH3 inhibitor, NOTCH3 Decoy, blocks IH development and mural cell d...
HemSCs and ECFCs in a 1:1 ratio were resuspended in Matrigel and implanted subcutaneously into immunocompromised mice. An adenovirus encoding NOTCH3 Decoy (N3 Decoy) or FC (control) was administered at either day 3 (H43, data not shown) or day 7 (H49) after implantation and IH development assessed until day 21 (schematic in Supplemental Figure 10A). (A) Detection of high blood flow by ultrasound Doppler of HemSC/ECFC xenografts prior to (day 7) and after (day 21) N3 Decoy and FC adenovirus injection. Xenograft area marked with yellow dotted line. White arrowheads mark Dopplerable blood flow (red). (B) Quantification of Doppler signal intensity normalized to implant area on day 7 and 21 (n = 2 populations; n = 4 implants each). *P < 0.05, Student’s t test. (C) H&E staining of N3 Decoy– and FC-treated xenograft sections. Arrowheads mark red blood cell–containing vessels. (D) Quantification of vessel density and caliber (n = 2 populations; n = 4 implants each). **P < 0.0005, Student’s t test. (E) N3 Decoy and FC HemSC/ECFC xenograft sections stained for αSMA. White arrowheads mark vessel surrounded by αSMA+ mural cells. Yellow arrowheads mark vessel surrounded by mural cells that express low levels of αSMA. (F) αSMA+ mural cell density determined as mean mural cell αSMA signal intensity normalized to IH endothelial GLUT1 signal intensity. Average mural cell αSMA expression determined as mean αSMA signal intensity–normalized DAPI+αSMA+ cell number (n = 2 populations; n = 4 implants each). n.s., not significant. **P < 0.0005, ***P < 0.01, Student’s t test. Scale bars: 50 μm. αSMA, α smooth muscle actin; ECFC, endothelial colony-forming cell; GLUT1, glucose transporter 1; HemSC, hemangioma stem cell; IH, infantile hemangioma, MC, mural cell; N3 Decoy; NOTCH3 Decoy; Scr, scrambled.